184 related articles for article (PubMed ID: 35707383)
1. Evaluation of
Assiry AA; Bhavikatti SK; Althobaiti FA; Mohamed RN; Karobari MI
Biomed Res Int; 2022; 2022():5870443. PubMed ID: 35707383
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of medicinal herbs as a potential therapeutic option against SARS-CoV-2 targeting its main protease.
Upadhyay S; Tripathi PK; Singh M; Raghavendhar S; Bhardwaj M; Patel AK
Phytother Res; 2020 Dec; 34(12):3411-3419. PubMed ID: 32748969
[TBL] [Abstract][Full Text] [Related]
3. Anti-HSV-2 activity of Terminalia chebula Retz extract and its constituents, chebulagic and chebulinic acids.
Kesharwani A; Polachira SK; Nair R; Agarwal A; Mishra NN; Gupta SK
BMC Complement Altern Med; 2017 Feb; 17(1):110. PubMed ID: 28196487
[TBL] [Abstract][Full Text] [Related]
4. Design and study of anticaries effect of different medicinal plants against S.mutans glucosyltransferase.
Mandava K; Batchu UR; Kakulavaram S; Repally S; Chennuri I; Bedarakota S; Sunkara N
BMC Complement Altern Med; 2019 Aug; 19(1):197. PubMed ID: 31375097
[TBL] [Abstract][Full Text] [Related]
5. In silico evaluation of inhibitory potential of triterpenoids from Azadirachta indica against therapeutic target of dengue virus, NS2B-NS3 protease.
Dwivedi VD; Tripathi IP; Mishra SK
J Vector Borne Dis; 2016; 53(2):156-61. PubMed ID: 27353586
[TBL] [Abstract][Full Text] [Related]
6. Multiple in vitro biological effects of phenolic compounds from Terminalia chebula var. tomentella.
Zhang XR; Qiao YJ; Zhu HT; Kong QH; Wang D; Yang CR; Zhang YJ
J Ethnopharmacol; 2021 Jul; 275():114135. PubMed ID: 33892063
[TBL] [Abstract][Full Text] [Related]
7. Comparative evaluation of the potential anti-spasmodic activity of
Tiwari BR; Naseeruddin Inamdar M; Orfali R; Alshehri A; Alghamdi A; Almadani ME; Alshehri S; Imam Rabbani S; Mohammed Basheeruddin Asdaq S
Saudi Pharm J; 2023 Sep; 31(9):101705. PubMed ID: 37576742
[TBL] [Abstract][Full Text] [Related]
8. In vitro antiplasmodial activity of some medicinal plants of Burkina Faso.
Ouattara LP; Sanon S; Mahiou-Leddet V; Gansané A; Baghdikian B; Traoré A; Nébié I; Traoré AS; Azas N; Ollivier E; Sirima SB
Parasitol Res; 2014 Jan; 113(1):405-16. PubMed ID: 24318747
[TBL] [Abstract][Full Text] [Related]
9. The development of Terminalia chebula Retz. (Combretaceae) in clinical research.
Bag A; Bhattacharyya SK; Chattopadhyay RR
Asian Pac J Trop Biomed; 2013 Mar; 3(3):244-52. PubMed ID: 23620847
[TBL] [Abstract][Full Text] [Related]
10. In-vitro evaluation of selected Egyptian traditional herbal medicines for treatment of Alzheimer disease.
Ali SK; Hamed AR; Soltan MM; Hegazy UM; Elgorashi EE; El-Garf IA; Hussein AA
BMC Complement Altern Med; 2013 May; 13():121. PubMed ID: 23721591
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of in vitro aldose reductase inhibitory potential of alkaloidal fractions of Piper nigrum, Murraya koenigii, Argemone mexicana, and Nelumbo nucifera.
Gupta S; Singh N; Jaggi AS
J Basic Clin Physiol Pharmacol; 2014 May; 25(2):255-65. PubMed ID: 24127538
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo antiplasmodial activity of three Rwandan medicinal plants and identification of their active compounds.
Muganga R; Angenot L; Tits M; Frédérich M
Planta Med; 2014 Apr; 80(6):482-9. PubMed ID: 24710900
[TBL] [Abstract][Full Text] [Related]
13. Azadirachta indica: A herbal panacea in dentistry - An update.
Lakshmi T; Krishnan V; Rajendran R; Madhusudhanan N
Pharmacogn Rev; 2015; 9(17):41-4. PubMed ID: 26009692
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effects of Egyptian folk medicines on human immunodeficiency virus (HIV) reverse transcriptase.
el-Mekkawy S; Meselhy MR; Kusumoto IT; Kadota S; Hattori M; Namba T
Chem Pharm Bull (Tokyo); 1995 Apr; 43(4):641-8. PubMed ID: 7541317
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Aristolochia indica L. and Piper nigrum L. methanol extract against centipede Scolopendra moristans L. using Wistar albino rats and screening of bioactive compounds by high pressure liquid chromatography: a polyherbal formulation.
Sivaraj D; Shanmugam S; Rajan M; Sasidharan SP; Sathyanarayanan S; Muniyandi K; Thangaraj P; de Souza Araújo AA
Biomed Pharmacother; 2018 Jan; 97():1603-1612. PubMed ID: 29793322
[TBL] [Abstract][Full Text] [Related]
16. Antimalarial Activities of a Therapeutic Combination of Azadirachta indica, Mangifera indica and Morinda lucida Leaves: A Molecular View of its Activity on Plasmodium falciparum Proteins.
Abdulai SI; Ishola AA; Bewaji CO
Acta Parasitol; 2023 Sep; 68(3):659-675. PubMed ID: 37474844
[TBL] [Abstract][Full Text] [Related]
17. Screening and identification of acetylcholinesterase inhibitors from Terminalia chebula fruits by immobilized enzyme on cellulose filter paper coupled with ultra-performance liquid chromatography-quadrupole time-of-flight mass spectrometry and molecular docking.
Li YJ; He FQ; Zhao HH; Li Y; Chen J
J Chromatogr A; 2022 Jan; 1663():462784. PubMed ID: 34974370
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the Antioxidant and Antidiabetic Potential of the Poly Herbal Formulation: Identification of Bioactive Factors.
Uddandrao VVS; Brahmanaidu P; Ganapathy S
Cardiovasc Hematol Agents Med Chem; 2020; 18(2):111-123. PubMed ID: 32031078
[TBL] [Abstract][Full Text] [Related]
19. An in vitro study to determine the effect of Terminalia chebula extract and its formulation on Streptococcus mutans.
Nayak SS; Ankola AV; Metgud SC; Bolmal UK
J Contemp Dent Pract; 2014 May; 15(3):278-82. PubMed ID: 25307806
[TBL] [Abstract][Full Text] [Related]
20. Revolutionizing the effect of Azadirachta indica extracts on edema induced changes in C-reactive protein and interleukin-6 in albino rats: in silico and in vivo approach.
Ammara A; Sobia A; Nureen Z; Sohail A; Abid S; Aziz T; Nahaa MA; Rewaa SJ; Ahellah MJ; Nouf SAA; Nehad AS; Manal YS; Amnah AA; Majid A; Abdulhakeem SA; Anas SD; Saad A
Eur Rev Med Pharmacol Sci; 2023 Jul; 27(13):5951-5963. PubMed ID: 37458623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
